Information sent to healthcare professionals in September 2008 about the safety of medicines

A list of letters sent to healthcare professionals in September 2008, to inform of new safety information and advice.

Date issued
Product
Safety information
03/09/2008
New formulation affects medicines that can be infused simultaneously through Y-site delivery
05/09/2008
Use when response to usual laxative treatment has not been sufficient in adults with advanced illness who have opioid-related constipation. To avoid risk of overdose, patients and carers should be made aware that one vial does not always contain the appropriate single dose 
15/09/2008
Fibrotic cardiac valvulopathy

See also:
› Letter from the Chief Medical Officer, Chief Nursing Officer, and Chief Pharmaceutical Officer sent on Sept 16, 2008, about the ORACLE Children Study (external link).
› ORACLE children study: Outcomes after use of antibiotics in preterm labour

Page last modified: 02 October 2008